🇺🇸 FDA

Intelligence · Clinical Pipeline

Oncology · Phase II

Oncology programs at Phase II — ClinicalTrials.gov pipeline intelligence.

Programs
2,640

Quick answer

Oncology Phase II programs: NovaPharmaNews indexes 2,640 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.

Top sponsors

Page 53 of 55

  1. cemiplimab

    Regeneron UK Limited

    Cutaneous Basal Cell Carcinoma

    phase 2 small molecule active

    1 trial

  2. cemiplimab

    Regeneron UK Limited

    Carcinoma, Basal Cell

    phase 2 small molecule completed

    1 trial

  3. cemiplimab

    Regeneron UK Limited

    Advanced Cutaneous Squamous Cell Carcinoma

    phase 2 small molecule completed

    1 trial

  4. cemiplimab (monotherapy)

    Regeneron UK Limited

    Relapsed Solid Tumor

    phase 2 small molecule terminated

    1 trial

  5. certepetide

    LISATA THERAPEUTICS, INC.

    Pancreas Cancer

    phase 2 small molecule terminated

    1 trial

  6. certepetide

    LISATA THERAPEUTICS, INC.

    Cholangiocarcinoma

    phase 2 small molecule active

    1 trial

  7. cetrelimab, JNJ-63723283

    Janssen-Cilag International N.V.

    Advanced Stage Solid Tumors

    phase 2 small molecule active

    1 trial

  8. cetuximab (Erbitux)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Esophageal Cancer

    phase 2 small molecule completed

    1 trial

  9. chemotherapy: TS-1, Leucovorin and Gemcitabine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pancreatic Adenocarcinoma

    phase 2 small molecule completed

    1 trial

  10. chidamide + camrelizumab

    The First People's Hospital of Lianyungang

    Esophageal Squamous Cell Carcinoma

    phase 2 small molecule active

    1 trial

  11. chidamide，fulvestrant

    The First People's Hospital of Lianyungang

    Hormone Receptor-positive Advanced Breast Cancer

    phase 2 small molecule active

    1 trial

  12. cisplatin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Esophageal Squamous Cell Carcinoma

    phase 2 small molecule active

    1 trial

  13. cisplatin

    Cardiff Oncology

    Bladder Cancer

    phase 2 small molecule completed

    2 trials

  14. cisplatin and 5-Fu combined with nimotuzumab

    The First People's Hospital of Lianyungang

    Stage IV Nasopharyngeal Carcinoma

    phase 2 small molecule completed

    1 trial

  15. combination with Disitamab Vedotin and with Tislelizumab and Capecitabine

    Hospital Authority, Hong Kong

    Gastric Cancer

    phase 2 small molecule active

    1 trial

  16. cytarabine

    Teva Pharma GmbH

    Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome

    phase 2 small molecule terminated

    1 trial

  17. delolimogene mupadenorepvec

    Chongqing Precision Biotech Co., Ltd

    Malignant Melanoma

    phase 2 gene therapy completed

    1 trial

  18. disitamab vedotin

    Pfizer

    Urothelial Carcinoma

    phase 2 small molecule active

    1 trial

  19. docetaxel

    Sanofi Pasteur

    Nasopharyngeal Neoplasms

    phase 2 small molecule completed

    1 trial

  20. docetaxel and ketoconazole

    Hospital Authority, Hong Kong

    Metastatic Breast Cancer

    phase 2 small molecule completed

    1 trial

  21. docetaxel+CDDP

    Solid Biosciences

    Head and Neck Squamous Cell Carcinoma

    phase 2 small molecule terminated

    1 trial

  22. docetaxel, cisplatin, fluorouracil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Locally Advanced Head and Neck Carcinoma

    phase 2 small molecule completed

    1 trial

  23. docetaxol, cisplatin, capecitabine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Advanced Breast Cancer

    phase 2 small molecule active

    1 trial

  24. donor-derived NK cell infusion

    Chongqing Precision Biotech Co., Ltd

    Non-small Cell Lung Cancer

    phase 2 mab active

    1 trial

  25. doxorubicin, docetaxel

    Hospital Authority, Hong Kong

    Metastatic Breast Cancer

    phase 2 small molecule completed

    1 trial

  26. entinostat

    Syndax Pharmaceuticals

    Estrogen Receptor-negative Breast Cancer

    phase 2 small molecule terminated

    1 trial

  27. entinostat

    Syndax Pharmaceuticals

    Epithelial Ovarian Cancer

    phase 2 small molecule completed

    1 trial

  28. entinostat

    Syndax Pharmaceuticals

    Breast Cancer

    phase 2 small molecule completed

    4 trials

  29. eribulin mesylate + erlotinib

    Eisai Co.,

    Non-small Cell Lung Cancer

    phase 2 small molecule completed

    1 trial

  30. erlotinib [Tarceva]

    Hoffmann-La Roche

    Non-Small Cell Lung Cancer

    phase 2 small molecule completed

    1 trial

  31. erlotinib and bexarotene

    LIGAND PHARMACEUTICALS INC

    Carcinoma, Non-small-cell Lung

    phase 2 small molecule completed

    1 trial

  32. everolimus

    United Therapeutics Europe Ltd

    Malignant Peripheral Nerve Sheath Tumors

    phase 2 small molecule completed

    1 trial

  33. evorpacept

    ALX ONCOLOGY HOLDINGS INC

    Head and Neck Cancer

    phase 2 small molecule active

    2 trials

  34. experimental group x-MAP

    The First People's Hospital of Lianyungang

    Metastatic Colorectal Cancer (mCRC)

    phase 2 other active

    1 trial

  35. farletuzumab ecteribulin

    Bristol-Myers Squibb Australia Pty Ltd

    Metastatic Non-Small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  36. farletuzumab ecteribulin, LENVIMA 4 mg hard capsules, LENVIMA 10 mg hard capsules

    Eisai Co.,

    Solid tumors in 4 tumor types: platinum resistant ovarian cancer, triple-negative breast cancer (TNBC), endometrial cancer (EC), and non-small cell lung cancer adenocarcinoma; NSCLC).

    phase 2 small molecule active

    1 trial

  37. favezelimab, quavonlimab, Lenvatinib, KEYTRUDA 25 mg/mL concentrate for solution for infusion, Lenvatinib

    Merck Sharp and Dohme

    Stage IV non-small cell lung cancer

    phase 2 small molecule active

    1 trial

  38. forodesine HCl

    Biocryst

    Chronic Lymphocytic Leukemia (CLL)

    phase 2 small molecule completed

    1 trial

  39. forodesine hydrochloride

    Biocryst

    Lymphoma

    phase 2 small molecule completed

    2 trials

  40. forodesine hydrochloride (BCX-1777)

    Biocryst

    Leukemia, T-Cell

    phase 2 small molecule completed

    1 trial

  41. forodesine hydrochloride (BCX-1777)

    Biocryst

    Leukemia, Lymphocytic, Chronic

    phase 2 small molecule completed

    1 trial

  42. forodesine hydrochloride (BCX-1777)

    Biocryst

    B-cell Acute Lymphoblastic Leukemia

    phase 2 small molecule completed

    1 trial

  43. fostamatinib

    RIGEL PHARMACEUTICALS INC

    Lymphoma

    phase 2 small molecule completed

    1 trial

  44. fruquintinib

    Takeda

    Colon Cancer

    phase 2 small molecule active

    1 trial

  45. furmonertinib

    Sun Yat-sen University

    Non-small Cell Lung Cancer Metastatic

    phase 2 small molecule completed

    1 trial

  46. ganetespib

    United Therapeutics Europe Ltd

    Malignant Peripheral Nerve Sheath Tumors (MPNST)

    phase 2 small molecule completed

    1 trial

  47. gemcitabine

    Yung NA

    Muscle Invasive Bladder Urothelial Carcinoma

    phase 2 small molecule active

    1 trial

  48. gemcitabine and cisplatin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Squamous Cell Carcinoma

    phase 2 small molecule completed

    1 trial

Frequently asked questions

How many oncology Phase II programs exist?

2,640 programs match both the therapeutic area and stage filters in our published index.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.